Xiong Ni

#168 Changhai Road
Shanghai, 200433, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Clinical Outcomes of Rh(D)-Incompatible Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Centre Retrospective Case Series with a Narrative Literature Review.

Clinical Outcomes of Rh(D)-Incompatible Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Centre Retrospective Case Series with a Narrative Literature Review.

Journal: Journal of blood medicine

Published: May 18, 2026

A randomized trial of GVHD prophylaxis in haploidentical PBSC transplantation: ATG, PTCy, and low-dose combination therapy.

A randomized trial of GVHD prophylaxis in haploidentical PBSC transplantation: ATG, PTCy, and low-dose combination therapy.

Journal: Blood

Published: November 25, 2025

A molecular-based risk score for predicting leukemia-free survival in adult AML patients undergoing Allo-HSCT.

A molecular-based risk score for predicting leukemia-free survival in adult AML patients undergoing Allo-HSCT.

Journal: iScience

Published: April 02, 2025

Anti-CD4 monoclonal antibody prevents chronic graft-versus-host disease in mice by inducing immune tolerance of CD8+ T cells and alleviating thymus injury.

Anti-CD4 monoclonal antibody prevents chronic graft-versus-host disease in mice by inducing immune tolerance of CD8+ T cells and alleviating thymus injury.

Journal: Frontiers in immunology

Published: July 06, 2024

Integrative proteogenomic and pharmacological landscape of acute myeloid leukaemia.

Integrative proteogenomic and pharmacological landscape of acute myeloid leukaemia.

Journal: Science bulletin

Published: June 24, 2024

Rapid screening of acute promyelocytic leukaemia in daily batch specimens: A novel artificial intelligence-enabled approach to bone marrow morphology.

Rapid screening of acute promyelocytic leukaemia in daily batch specimens: A novel artificial intelligence-enabled approach to bone marrow morphology.

Journal: Clinical and translational medicine

Published: April 10, 2024

Stable Expressed DNMT3A Mutants Predict a Poor Prognosis in Acute Myeloid Leukemia Patients Without Receiving Hematopoietic Stem Cell Transplantation.

Stable Expressed DNMT3A Mutants Predict a Poor Prognosis in Acute Myeloid Leukemia Patients Without Receiving Hematopoietic Stem Cell Transplantation.

Journal: MedComm

Published: March 29, 2024

More fear reduction, better posttraumatic stress symptoms resilience: 1 year longitudinal study based on the psychological trauma recover project-5-6.

More fear reduction, better posttraumatic stress symptoms resilience: 1 year longitudinal study based on the psychological trauma recover project-5-6.

Journal: Psychological trauma : theory, research, practice and policy

Published: February 29, 2024

Effect of sustained measurable residue disease negativity and post-remission treatment selection on the prognosis of acute lymphoblastic leukemia in adults.

Effect of sustained measurable residue disease negativity and post-remission treatment selection on the prognosis of acute lymphoblastic leukemia in adults.

Journal: Cancer medicine

Published: January 29, 2024

Comparison of Stem Cell Transplantation Using Unrelated, Haploidentical, and Sibling Donors for Patients with Acquired Severe Aplastic Anemia: A Single-Center Retrospective Cohort Study.

Comparison of Stem Cell Transplantation Using Unrelated, Haploidentical, and Sibling Donors for Patients with Acquired Severe Aplastic Anemia: A Single-Center Retrospective Cohort Study.

Journal: Transplantation and cellular therapy

Published: September 09, 2023

CEAC (oral semustine, etoposide, cytarabine and cyclophosphamide) vs BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning regimen of autologous stem cell transplantation for diffuse large B-cell lymphoma: a post-hoc, propensity score-matched, cohort study in Chinese patients.

CEAC (oral semustine, etoposide, cytarabine and cyclophosphamide) vs BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning regimen of autologous stem cell transplantation for diffuse large B-cell lymphoma: a post-hoc, propensity score-matched, cohort study in Chinese patients.

Journal: Annals of hematology

Published: July 27, 2023

Sequential autologous and allogeneic stem cell transplantation for treatment of primary plasma cell leukemia: A case report.

Sequential autologous and allogeneic stem cell transplantation for treatment of primary plasma cell leukemia: A case report.

Journal: Molecular and clinical oncology

Published: March 21, 2023

Showing 1-12 of 44

Last Updated: 09/26/2026